lanthanum carbonate has been researched along with losartan potassium in 1 studies
Studies (lanthanum carbonate) | Trials (lanthanum carbonate) | Recent Studies (post-2010) (lanthanum carbonate) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
---|---|---|---|---|---|
390 | 87 | 218 | 24,390 | 2,493 | 5,408 |
Protein | Taxonomy | lanthanum carbonate (IC50) | losartan potassium (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.53 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Kitai, M; Maruyama, N; Maruyama, T; Nagura, C; Otsuki, T; Shibahara, N; Tomita, H; Yoshida, Y | 1 |
1 trial(s) available for lanthanum carbonate and losartan potassium
Article | Year |
---|---|
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
Topics: Erythropoietin; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome | 2018 |